Roles of rhamnolipids in pharmaceutics: medicine carrier, medicine booster and activator for the immune system and in other biological processes.
• Treatment of wounds, including chronic ulcer, bedsores, burns
(including radioactive burns)
• To enhance the effect of antibiotics in the treatment of
infections
• As oral agents for improving the absorption of various
drugs.
• Use in re-epithelialization of mucous membranes, especially
for the healing of the mucous membranes, in the treatment and
prevention of gum diseases such as gingivitis and periodontal
regeneration.
• Treatment of autoimmune diseases. The treatment will be in
organ-specific autoimmune diseases and also in non-organ
specific autoimmune diseases psoriasis, lichen planus, lupus
erythematosus, ichthyosis, AIDS, Alzheimer's disease,
Parkinson's disease and Amyotrophic Lateral Sclerosis
(ALS)
• Treatment of dermatological diseases
• The treatment of diseases associated with obesity: the
metabolic syndrome, arterial hypertension, type 2 diabetes,
nonalcoholic fatty liver disease or obesity-related
obesity
• Treatment of rhinitis and sinusitis
• Create based on rhamnolipid liposomes for use as
microcapsules for drugs, proteins, nucleic acids, dyes and
other compounds. Rhamnolipid liposomes have an affinity for
biological tissues, are non-toxic and biodegradable, with long
lifetimes.
• Stimulating the production in the bone marrow of neutrophils
and monocytes responsible for humoral immunity;
• Possessing the immunosuppressive activity to T lymphocytes
(treatment of autoimmune diseases);
• The inhibition of a number of enzymes (treatment of
autoimmune diseases);
• Antiproliferative activity
• Stimulating the proliferation of keratinocytes involved in
the healing process (reepithelialization) of the wounds;
• Reducing fibrosis in wound healing;
• Rhamnolipids in pharmaceutical preparations for oral use
increase the permeability of cell membranes, resulting in
better absorption of drugs;
• Rhamnolipids reduce the level of cytokines (in vivo);
• Treatment of conditions associated with obesity. Rhamnolipids
affect the level of triglycerides, creatinine, alanine
transaminaza, reduces blood sugar levels.